Modern Veterinary Therapeutics, LLC announces that the Veterinary Drugs Directorate (VDD) has approved MaprelinTM XP-10 (peforelin injection – 75μg/mL; DIN 02465078) in Canada. MaprelinTM XP-10, approved for use in swine, is presented in 10mL and 50mL vials. MaprelinTM XP-10 is a sterile injectable synthetic gonadotropin releasing hormone for the induction of the estrus cycle in sows after weaning, and in sexually mature gilts following therapy to inhibit the estrus cycle with progestogens. “Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada demonstrating our commitment to the ethical animal production and animal welfare in Canada. Indeed, peforelin is produced synthetically. Finally, the Canadian swine industry has an alternative to the Pregnant Mare Serum Gonadotropin (PMSG) which is obtained via abortion of pregnant mares. The use of MaprelinTM XP- 10 is an ethical choice” said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.
